Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-5-20
pubmed:abstractText
To date, very few Ag-based regimens have been defined that could expand T regulatory (Treg) cells to reverse autoimmunity. Additional understanding of Treg function with respect to specificity and broad suppression should help overcome these limitations. Ig-proteolipid protein (PLP)1, an Ig carrying a PLP1 peptide corresponding to amino acid residues 139-151 of PLP, displayed potent tolerogenic functions and proved effective against experimental allergic encephalomyelitis (EAE). In this study, we took advantage of the Ig-PLP1 system and the PLP1-specific TCR transgenic 5B6 mouse to define a regimen that could expand Ag-specific Treg cells in vivo and tested for effectiveness against autoimmunity involving diverse T cell specificities. The findings indicate that in vivo exposure to aggregated Ig-PLP1 drives PLP1-specific 5B6 TCR transgenic cells to evolve as Treg cells expressing CD25, CTLA-4, and Foxp3 and producing IL-10. These Treg cells were able to suppress PLP1 peptide-induced EAE in both SJL/J and F(1) (SJL/J x C57BL/6) mice. However, despite being effective against disease induced with a CNS homogenate, the Treg cells were unable to counter EAE induced by a myelin basic protein or a myelin oligodendrocyte glycoprotein peptide. Nevertheless, activation with Ag before transfer into the host mice supports suppression of both myelin oligodendrocyte glycoprotein- and myelin basic protein peptide-induced EAE. Thus, it is suggested that activation of Treg cells by the cognate autoantigen is necessary for operation of broad suppressive functions.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6772-80
pubmed:dateRevised
2011-8-26
pubmed:meshHeading
pubmed-meshheading:15905518-Amino Acid Sequence, pubmed-meshheading:15905518-Animals, pubmed-meshheading:15905518-Bystander Effect, pubmed-meshheading:15905518-Cell Proliferation, pubmed-meshheading:15905518-Encephalomyelitis, Autoimmune, Experimental, pubmed-meshheading:15905518-Epitopes, T-Lymphocyte, pubmed-meshheading:15905518-Female, pubmed-meshheading:15905518-Lymphocyte Activation, pubmed-meshheading:15905518-Male, pubmed-meshheading:15905518-Mice, pubmed-meshheading:15905518-Mice, Inbred C57BL, pubmed-meshheading:15905518-Mice, Knockout, pubmed-meshheading:15905518-Mice, Transgenic, pubmed-meshheading:15905518-Molecular Sequence Data, pubmed-meshheading:15905518-Myelin Proteolipid Protein, pubmed-meshheading:15905518-Peptide Fragments, pubmed-meshheading:15905518-Rats, pubmed-meshheading:15905518-Receptors, Antigen, T-Cell, pubmed-meshheading:15905518-Recurrence, pubmed-meshheading:15905518-Severity of Illness Index, pubmed-meshheading:15905518-T-Lymphocytes, Regulatory
pubmed:year
2005
pubmed:articleTitle
Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
pubmed:affiliation
Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, 65212, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural